474 related articles for article (PubMed ID: 11107180)
1. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N
Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180
[TBL] [Abstract][Full Text] [Related]
2. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
Bown N; Cotterill S; Lastowska M; O'Neill S; Pearson AD; Plantaz D; Meddeb M; Danglot G; Brinkschmidt C; Christiansen H; Laureys G; Speleman F; Nicholson J; Bernheim A; Betts DR; Vandesompele J; Van Roy N
N Engl J Med; 1999 Jun; 340(25):1954-61. PubMed ID: 10379019
[TBL] [Abstract][Full Text] [Related]
3. Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore.
Yong MH; Hwang WS; Knight LA; Fung W; Chan MY; Seow WT; Chui CH
Singapore Med J; 2009 Nov; 50(11):1090-4. PubMed ID: 19960166
[TBL] [Abstract][Full Text] [Related]
4. Promiscuous translocations of chromosome arm 17q in human neuroblastomas.
Lastowska M; Roberts P; Pearson AD; Lewis I; Wolstenholme J; Bown N
Genes Chromosomes Cancer; 1997 Jul; 19(3):143-9. PubMed ID: 9218994
[TBL] [Abstract][Full Text] [Related]
5. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Clin Cancer Res; 2003 Oct; 9(13):4835-40. PubMed ID: 14581355
[TBL] [Abstract][Full Text] [Related]
6. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
Godfried MB; Veenstra M; v Sluis P; Boon K; v Asperen R; Hermus MC; v Schaik BD; Voûte TP; Schwab M; Versteeg R; Caron HN
Oncogene; 2002 Mar; 21(13):2097-101. PubMed ID: 11960382
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group.
Lastowska M; Nacheva E; McGuckin A; Curtis A; Grace C; Pearson A; Bown N
Genes Chromosomes Cancer; 1997 Mar; 18(3):162-9. PubMed ID: 9071568
[TBL] [Abstract][Full Text] [Related]
8. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B
Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859
[TBL] [Abstract][Full Text] [Related]
9. Regions syntenic to human 17q are gained in mouse and rat neuroblastoma.
Łastowska M; Chung YJ; Cheng Ching N; Haber M; Norris MD; Kees UR; Pearson AD; Jackson MS
Genes Chromosomes Cancer; 2004 Jun; 40(2):158-63. PubMed ID: 15101050
[TBL] [Abstract][Full Text] [Related]
10. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
Bown N; Lastowska M; Cotterill S; O'Neill S; Ellershaw C; Roberts P; Lewis I; Pearson AD;
Med Pediatr Oncol; 2001 Jan; 36(1):14-9. PubMed ID: 11464868
[TBL] [Abstract][Full Text] [Related]
11. Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1.
Spieker N; Beitsma M; Van Sluis P; Chan A; Caron H; Versteeg R
Genes Chromosomes Cancer; 2001 Jun; 31(2):172-81. PubMed ID: 11319804
[TBL] [Abstract][Full Text] [Related]
12. MYCN overexpression is associated with unbalanced copy number gain, altered nuclear location, and overexpression of chromosome arm 17q genes in neuroblastoma tumors and cell lines.
Kuzyk A; Booth S; Righolt C; Mathur S; Gartner J; Mai S
Genes Chromosomes Cancer; 2015 Oct; 54(10):616-28. PubMed ID: 26171843
[TBL] [Abstract][Full Text] [Related]
13. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.
Stallings RL; Carty P; McArdle L; Mullarkey M; McDermott M; O'Meara A; Ryan E; Catchpoole D; Breatnach F
Cytogenet Genome Res; 2004; 106(1):49-54. PubMed ID: 15218241
[TBL] [Abstract][Full Text] [Related]
14. Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping.
Stark B; Jeison M; Bar-Am I; Glaser-Gabay L; Mardoukh J; Luria D; Feinmesser M; Goshen Y; Stein J; Abramov A; Zaizov R; Yaniv I
Genes Chromosomes Cancer; 2002 Jul; 34(3):313-24. PubMed ID: 12007192
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.
Spitz R; Hero B; Westermann F; Ernestus K; Schwab M; Berthold F
Genes Chromosomes Cancer; 2002 Jul; 34(3):299-305. PubMed ID: 12007190
[TBL] [Abstract][Full Text] [Related]
16. Alternative pathways of MYCN gene copy number increase in primary neuroblastoma tumors.
Valent A; Guillaud-Bataille M; Farra C; Lozach F; Spengler B; Terrier-Lacombe MJ; Valteau-Couanet D; Danglot G; Lenoir GM; Brison O; Bénard J; Bernheim A
Cancer Genet Cytogenet; 2004 Aug; 153(1):10-5. PubMed ID: 15325088
[TBL] [Abstract][Full Text] [Related]
17. Detection of MYCN gene amplification and deletions of chromosome 1p in neuroblastoma by in situ hybridization using routine histologic sections.
Leong PK; Thorner P; Yeger H; Ng K; Zhang Z; Squire J
Lab Invest; 1993 Jul; 69(1):43-50. PubMed ID: 8331897
[TBL] [Abstract][Full Text] [Related]
18. [Amplification of N-myc in neuroblastoma: paradigm for clinical use of an oncogene alteration].
Schwab M
Klin Padiatr; 1990; 202(4):197-201. PubMed ID: 2203936
[TBL] [Abstract][Full Text] [Related]
19. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.
Squire JA; Thorner PS; Weitzman S; Maggi JD; Dirks P; Doyle J; Hale M; Godbout R
Oncogene; 1995 Apr; 10(7):1417-22. PubMed ID: 7731693
[TBL] [Abstract][Full Text] [Related]
20. Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma.
Wimmer K; Zhu XX; Lamb BJ; Kuick R; Ambros P; Kovar H; Thoraval D; Elkahloun A; Meltzer P; Hanash SM
Med Pediatr Oncol; 2001 Jan; 36(1):75-9. PubMed ID: 11464910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
